BPC-157 (Body Protection Compound-157) is a synthetic 15-amino-acid peptide originally derived from a protein found in human gastric juice. It has been the subject of numerous preclinical studies, primarily in rodents.
Published research has examined its effects in various experimental models of tissue injury, gastrointestinal damage, and inflammatory conditions. Most of the available data come from animal studies and in-vitro work. Human clinical evidence remains very limited.
As of mid-2026, BPC-157 is not an FDA-approved drug. It continues to be classified and sold in the research chemical category by legitimate suppliers. Researchers interested in this compound typically review primary literature on mechanisms such as angiogenesis, nitric oxide pathways, and growth factor modulation in controlled laboratory settings.
Any product labeled BPC-157 offered through research channels is intended solely for laboratory investigation and is not for human consumption.
Leave a Reply